Noble Energy to Present at Upcoming Energy Conference
Jun 22, 2017 21:00 pm UTC| Business
Houston, June 22, 2017 -- Noble Energy, Inc. (NYSE: NBL) announced today that David L. Stover, the Company’s Chairman, President CEO, will present at the J.P. Morgan Energy Equity Investor Conference on Tuesday, June...
PRESIDENT BILL CLINTON TO ADDRESS THE NATION’S MAYORS IN MIAMI BEACH SATURDAY, JUNE 24
Jun 22, 2017 20:59 pm UTC| Business
Washington, D.C, June 22, 2017 -- President Bill Clinton will address the nation’s mayors this week during the U.S. Conference of Mayors 85th Annual Meeting, which runs from Friday, June 23 to Monday, June 26 at the...
Willbros Announces Awards Valued at $68 Million
Jun 22, 2017 20:49 pm UTC| Business
Oil Gas awards total $50 million UTD contract extensions of $18 million HOUSTON, June 22, 2017 -- Willbros Group, Inc. (NYSE:WG) today announced its Oil Gas segment has executed two contracts and its Utility TD...
Oxford Immunotec Announces National Reimbursement for the T-SPOT®.TB Test in France
Jun 22, 2017 20:43 pm UTC| Business
OXFORD, United Kingdom and MARLBOROUGH, Mass., June 22, 2017 -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the...
Jun 22, 2017 20:33 pm UTC| Business
IRVINE, Calif., June 22, 2017 -- Khang Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Sky Solar Holdings, Ltd. (“Sky Solar” or the “Company”) (Nasdaq:SKYS). Investors who purchased or...
T-Mobile US, Inc. (Nasdaq:TMUS) to Ring The Nasdaq Stock Market Opening Bell
Jun 22, 2017 20:31 pm UTC| Business
ADVISORY, June 22, 2017 -- What: T-Mobile US, Inc. (Nasdaq:TMUS), America’s Un-carrier, will visit the Nasdaq MarketSite in Times Square to celebrate its support of LBGTQ Pride Month activities. T-Mobile participates...
Idera Announces FDA Orphan Drug Designation for IMO-2125 for the Treatment of Melanoma
Jun 22, 2017 20:30 pm UTC| Business
CAMBRIDGE, Mass. and EXTON, Pa., June 22, 2017 -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and...